Drug Topics published a randomized controlled trial in Lancet Microbe examining the interaction between live flu vaccines and bacterial colonization, revealing that administering the live attenuated influenza vaccine to previously unvaccinated 2-year-olds transiently increases Streptococcus pneumoniae carriage density, doubling the short-term odds of household transmission within 14 days post-vaccination.
Public source
Publisher name
Public post
Examining the interaction between live flu vaccines and bacterial colonization: A randomized controlled trial published in Lancet Microbe reveals that administering the…
Company
Drug Topics
- Industry
- Book and Periodical Publishing
- Location
- North Olmsted, US
- Company size
- 2–10 employees
About Drug Topics
Drug Topics is the top-ranked monthly retail pharmacy publication. Since 1857, pharmacist readers have received timely news on all phases of community, retail, and health-system issues and trends affecting the practice of pharmacy. We offer a forum for pharmacists to share practical ideas for better pharmacy management and patient care. We proudly serve 155,000 readers.
See moreLatest activity
Latest activity from Drug Topics
6 signals
Research & Knowledge
Drug Topics published a summary updating the framework for adult migraine prevention to provide clearer thresholds for initiating preventive therapy, selecting treatment options, and weighing efficacy, tolerability, long-term safety, and cost.
Presence & Recognition
Drug Topics featured Pharmaceutical Care Management Association CEO David Marin and National Community Pharmacists Association CEO Douglas Hoey discussing the PBM-pharmacy divide on prescription drug costs.
Presence & Recognition
Drug Topics is hosting the Total Pharmacy Solutions Summit Fall 2026 on Saturday, September 19, for independent and community pharmacists.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Microbiology Society
Microbiology Society published a review in the Journal of Medical Microbiology regarding the future of tetracyclines, noting that resistance to third-generation compounds is rising.
Research & Knowledge
Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News reports a new study from Children's Hospital of Philadelphia challenging the assumption that infant C. difficile colonization is harmless, finding that it can reshape the developing gut and immune system with potentially lasting health effects.
Research & Knowledge
Center for Infectious Disease Research and Policy (CIDRAP)
Center for Infectious Disease Research and Policy (CIDRAP) published a review of influenza immunizations screening over 5,800 studies and identifying 69 newly published studies, including 21 randomized control trials.
Research & Knowledge
Global Antibiotic R&D Partnership (GARDP)
Global Antibiotic R&D Partnership (GARDP) published new findings from the PediCAP trial published in The Lancet Group suggesting that for many young children, the answer is no, once a child has received at least 24 hours of antibiotics through a vein, improved clinically, and can take medicines by mouth, they can safely switch to oral amoxicillin or co-amoxiclav.
Research & Knowledge
The Lancet Group